Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva M Murauer

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 13, 2017
COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis BullosaStefan Hainzl, Patricia Peking, Thomas Kocher, et al.
International Journal of Molecular Sciences|February 15, 2022
5'RNA <i>Trans</i>-Splicing Repair of <i>COL7A1</i> Mutant Transcripts in Epidermolysis BullosaElisabeth Mayr, Michael Ablinger, Thomas Lettner, et al.
Nucleic Acids Research|October 4, 2017
An RNA-targeted therapy for dystrophic epidermolysis bullosaPatricia Peking, Ulrich Koller, Blanca Duarte, et al.
International Journal of Molecular Sciences|March 11, 2023
<i>COL7A1</i> Editing via RNA <i>Trans</i>-Splicing in RDEB-Derived Skin EquivalentsBernadette Liemberger, Johannes Bischof, Michael Ablinger, et al.
The Journal of Investigative Dermatology|November 15, 2016
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem CellsJohann W Bauer, Josef Koller, Eva M Murauer, et al.
Scientific Reports|July 9, 2020
A novel humanized mouse model to study the function of human cutaneous memory T cells in vivo in human skinMaria M Klicznik, Ariane Benedetti, Laura M Gail, et al.
The Journal of Investigative Dermatology|September 18, 2020
QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical StudyOlivier Bornert, Marieke Hogervorst, Pauline Nauroy, et al.
Cell Communication and Signaling : CCS|April 12, 2020
A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomasMonika Wimmer, Roland Zauner, Michael Ablinger, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 13, 2017
COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis BullosaStefan Hainzl, Patricia Peking, Thomas Kocher, et al.
International Journal of Molecular Sciences|February 15, 2022
5'RNA <i>Trans</i>-Splicing Repair of <i>COL7A1</i> Mutant Transcripts in Epidermolysis BullosaElisabeth Mayr, Michael Ablinger, Thomas Lettner, et al.
Nucleic Acids Research|October 4, 2017
An RNA-targeted therapy for dystrophic epidermolysis bullosaPatricia Peking, Ulrich Koller, Blanca Duarte, et al.
International Journal of Molecular Sciences|March 11, 2023
<i>COL7A1</i> Editing via RNA <i>Trans</i>-Splicing in RDEB-Derived Skin EquivalentsBernadette Liemberger, Johannes Bischof, Michael Ablinger, et al.
The Journal of Investigative Dermatology|November 15, 2016
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem CellsJohann W Bauer, Josef Koller, Eva M Murauer, et al.
Scientific Reports|July 9, 2020
A novel humanized mouse model to study the function of human cutaneous memory T cells in vivo in human skinMaria M Klicznik, Ariane Benedetti, Laura M Gail, et al.
The Journal of Investigative Dermatology|September 18, 2020
QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical StudyOlivier Bornert, Marieke Hogervorst, Pauline Nauroy, et al.
Cell Communication and Signaling : CCS|April 12, 2020
A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomasMonika Wimmer, Roland Zauner, Michael Ablinger, et al.
Pageof 3